Dr Manzoor Koyakutty is a Professor at Amrita Center for Nanoscience and Molecular Medicine, Kochi. He has worked extensively in molecular mechanisms responsible for cancer progression, drug-resistance, and tumor immunology, and developed many novel cancer-nanomedicine formulations and immunotherapeutic for leukemia, liver tumor and glioblastoma. His lab currently investigates systemic immune-suppression in peripheral organs as well as local tumor-microenvironment and developing novel nano-bio engineering tools to overcome such immune-suppression.

He has published > 150 papers in peer reviewed journals including Biomaterials, Small, J. of Controlled Release, Sci. Reports, Int. J Immunopharmacology with H-index 48 and citation 10530, and filed 40 patents of which 20 granted and 06 licensed for translational development. He was elected as Fellow of National Academy of Science, India (2017), top 2% scientist by Stanford University rating, 2022, received Amrita University Faculty Gold Medal 2023, and Chancellors Award 2024.

During the Fulbright-Nehru Academic and Professional Excellence Fellowship, he is working with Dr Henry Brem and Dr Betty Tylor, Glioma Center, Johns Hopkins School of Medicine, USA, for the combinatorial targeting of brain tumor immuno-biology using intracranially injectable nano-hydrogel system. This work may help glioma patients to have better therapeutic outcome.